UnknownPhase 3NCT02406729
Phase III Trial to Evaluate Efficacy and Safety of a Tetravalent Dengue Vaccine
Studying Dengue fever
Last synced from ClinicalTrials.gov
ℹ
Clinical trial records are synced from ClinicalTrials.gov through automated extraction.
Report missing dataKey facts
- Sponsor
- Butantan Institute
- Principal Investigator
- Fernanda C Boulos, MD, PhDInstituto Butantan
- Intervention
- Dengue 1,2,3,4 (attenuated) vaccine(biological)
- Enrollment
- 16935 enrolled
- Eligibility
- 59 years · All sexes
- Timeline
- 2016 – 2024
Study locations (17)
- Fundação de Medicina Tropical Doutor Heitor Vieira Dourado, Manaus, Amazonas, Brazil
- Universidade Federal do Ceará, Fortaleza, Ceará, Brazil
- Instituto Gonçalo Muniz - Fiocruz Bahia, Simões Filho, Estado de Bahia, Brazil
- Universidade de Brasília, Brasília, Federal District, Brazil
- Universidade Federal de Mato Grosso do Sul, Campo Grande, Mato Grosso do Sul, Brazil
- Universidade Federal de Minas Gerais, Belo Horizonte, Minas Gerais, Brazil
- Hospital Universitário Júlio Müller da Universidade Federal de Mato Grosso, Cuiabá, Mount, Brazil
- Centro de Pesquisas Aggeu Magalhães - Fiocruz Pernambuco, Recife, Pernambuco, Brazil
- Hospital Escola da Universidade Federal de Pelotas (HEUFPel), Pelotas, Rio Grande do Sul, Brazil
- Hospital São Lucas da Pontificia Universidade Catolica do Rio Grande do Sul, Porto Alegre, Rio Grande do Sul, Brazil
- Centro de Pesquisas em Medicina Tropical de Rondônia (CEPEM), Porto Velho, Rondônia, Brazil
- Universidade Federal de Roraima - UFRR, Boa Vista, Roraima, Brazil
- Universidade Federal de Sergipe, Laranjeiras, Sergipe, Brazil
- Faculdade de Medicina de São José do Rio Preto - FAMERP, São José do Rio Preto, São Paulo, Brazil
- Santa Casa de Misericórdia de São Paulo - CSEBF, São Paulo, São Paulo, Brazil
- +2 more locations on ClinicalTrials.gov
Primary source
Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.
Open NCT02406729 on ClinicalTrials.govOther trials for Dengue fever
Additional recruiting or active studies for the same condition.
- RECRUITINGPHASE3NCT06891950Butantan-DV Vaccine in Elderly Populations (DEN-04-IB)Butantan Institute
- RECRUITINGNANCT07412483A Controlled Human Infection Model of DengueTan Tock Seng Hospital
- RECRUITINGPHASE3NCT06579755A Study of Dengue Tetravalent Vaccine (TDV) in Adults (Age 45 to 60 and >60 to 79 Years)Takeda
- RECRUITINGNCT07409857International Registry of Dengue Infection in Congenital Bleeding Disorders (DengueCBDR)Mahidol University
- ACTIVE NOT RECRUITINGPHASE3NCT07047521A Study on a New Tetravalent Dengue Vaccine (TDV) Formulation in Healthy AdultsTakeda
- ENROLLING BY INVITATIONPHASE2NCT07172100To Assess the Efficacy of Carica Papaya Leaf Extract in Improving Platelet Counts Among Pediatric Patients With Dengue-associated ThrombocytopeniaZiauddin Hospital
- RECRUITINGPHASE2NCT06551844Adaptive Dengue Antiviral Platform TrialOxford University Clinical Research Unit, Vietnam
- RECRUITINGNCT07007585Risk Factors for Hospitalization and Transfusion Criteria in Patients With Dengue Virus InfectionJose Ivan Rodriguez de Molina Serrano